Bayer

Bayer is a global pharmaceutical and life-sciences company that originated from natural-products discovery, building from a "star molecule" into a diversified drug and chemical giant, per a 2024 峰瑞资本 interview with researcher Liu Tiangang . In the pharma industry it is grouped alongside Pfizer as one of the Western majors that Chinese firms have yet to match in scale . Its drug-development work includes radiopharmaceuticals: Bayer brought the nuclear medicine Xofigo to market in 2013 for prostate cancer that has spread to bone, an early milestone in the modern wave of cancer-targeted radiotherapies before Novartis's later breakthroughs . The company has also been active in China through partnerships—Chinese digital-health startup Nuoxin Chuanglian (诺信创联) named Bayer among its 20-plus top-tier pharma collaborators as of 2020 —and through senior regional leadership: Lee Hee-yeol (李希烈), former Asia-Pacific president of Bayer and later Medtronic, has advised Chinese healthcare companies on global expansion through his role at VentureBlick, per a 2024 高榕创投 event . elsewhere's corpus does not cover more recent strategic shifts or financials.